| Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline CL Daley, JM Iaccarino, C Lange, E Cambau, RJ Wallace Jr, C Andrejak, ... Clinical Infectious Diseases 71 (4), e1-e36, 2020 | 1441* | 2020 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1414 | 2018 |
| Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management DW Denning, J Cadranel, C Beigelman-Aubry, F Ader, A Chakrabarti, ... European Respiratory Journal 47 (1), 45-68, 2015 | 889 | 2015 |
| LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement U Mack, GB Migliori, M Sester, HL Rieder, S Ehlers, D Goletti, A Bossink, ... European Respiratory Journal 33 (5), 956-973, 2009 | 851 | 2009 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 804 | 2021 |
| Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis R Diel, D Goletti, G Ferrara, G Bothamley, D Cirillo, B Kampmann, ... European Respiratory Journal 37 (1), 88-99, 2010 | 772 | 2010 |
| Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis M Sester, G Sotgiu, C Lange, C Giehl, E Girardi, GB Migliori, A Bossink, ... European Respiratory Journal 37 (1), 100-111, 2010 | 757 | 2010 |
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... Public Library of Science 9 (8), e1001300, 2012 | 756 | 2012 |
| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ... The lancet Respiratory medicine 5 (4), 291-360, 2017 | 742 | 2017 |
| The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ... European Respiratory Journal 36 (5), 1185-1206, 2010 | 602 | 2010 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 566 | 2018 |
| Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis G Sotgiu, R Centis, L D'Ambrosio, JWC Alffenaar, HA Anger, JA Caminero, ... European Respiratory Journal 40 (6), 1430-1442, 2012 | 509 | 2012 |
| Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes D Falzon, N Gandhi, GB Migliori, G Sotgiu, HS Cox, TH Holtz, ... European Respiratory Journal 42 (1), 156-168, 2013 | 508 | 2013 |
| Treatment of tuberculosis CR Horsburgh Jr, CE Barry III, C Lange New England Journal of Medicine 373 (22), 2149-2160, 2015 | 482 | 2015 |
| The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation A Blumenthal, S Ehlers, J Lauber, J Buer, C Lange, T Goldmann, H Heine, ... Blood 108 (3), 965-973, 2006 | 452 | 2006 |
| Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement C Lange, I Abubakar, JWC Alffenaar, G Bothamley, JA Caminero, ... European Respiratory Journal 44 (1), 23-63, 2014 | 436 | 2014 |
| Common patterns and disease-related signatures in tuberculosis and sarcoidosis J Maertzdorf, J Weiner 3rd, HJ Mollenkopf, T Network, T Bauer, A Prasse, ... Proceedings of the National Academy of Sciences 109 (20), 7853-7858, 2012 | 393 | 2012 |
| A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ... European Respiratory Journal 50 (6), 2017 | 364 | 2017 |
| Tuberculosis contact investigation in low prevalence countries: a European consensus CGM Erkens, M Kamphorst, I Abubakar, GH Bothamley, D Chemtob, ... European Respiratory Journal 36 (4), 925-949, 2010 | 359 | 2010 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 329 | 2020 |
Jan HeyckendorfUniversity Hospital Schleswig-Holstein (UKSH) in KielVerified email at uksh.de